Status: Not yet recruiting
A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa
This is a multicenter, double-blind, randomized controlled clinical trial to get high - level evidence on minocycline's efficacy and safety（100mg/d, 200mg/d) for Retinitis pigmentosa and to find the optimal treatment dose.
Participants needed: 126
Trial details
Phase: Phase 3Age: 18-60Biological sex: AllType: InterventionalSponsor: Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUpdated: Jul 24, 2025Locations: 1
Eligibility criteria
Age should be between 18 and 60 years old. [+3]
Allergic to tetracycline antibiotics. [+9]